Clinical trial NCT01704690 - References

Esophageal Cancer — Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer

Citation(s)

•   Anderson SE, Minsky BD, Bains M, Kelsen DP, Ilson DH
  Combined modality therapy in esophageal cancer: the Memorial experience. Semin Surg Oncol. 2003;21(4):228-32.
•   Bleiberg H, Conroy T, Paillot B, Lacave AJ, Blijham G, Jacob JH, Bedenne L, Namer M, De Besi P, Gay F, Collette L, Sahmoud T
  Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer. 1997 Jul;33(8):1216-20.
•   Bollschweiler E, Wolfgarten E, Gutschow C, Hölscher AH
  Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer. 2001 Aug 1;92(3):549-55.
•   Devesa SS, Blot WJ, Fraumeni JF Jr
  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998 Nov 15;83(10):2049-53.
•   Enzinger PC, Ilson DH, Kelsen DP
  Chemotherapy in esophageal cancer. Semin Oncol. 1999 Oct;26(5 Suppl 15):12-20. Review.
•   Ilson DH, Forastiere A, Arquette M, Costa F, Heelan R, Huang Y, Kelsen DP
  A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus. Cancer J. 2000 Sep-Oct;6(5):316-23.
•   Ilson DH
  Oesophageal cancer: new developments in systemic therapy. Cancer Treat Rev. 2003 Dec;29(6):525-32. Review.
•   Koshy M, Esiashvilli N, Landry JC, Thomas CR Jr, Matthews RH
  Multiple management modalities in esophageal cancer: combined modality management approaches. Oncologist. 2004;9(2):147-59. Review.
•   Lundberg BB, Risovic V, Ramaswamy M, Wasan KM
  A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration. J Control Release. 2003 Jan 9;86(1):93-100.
•   Mu L, Feng SS
  A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release. 2003 Jan 9;86(1):33-48.
•   Mu L, Feng SS
  Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). J Control Release. 2002 Apr 23;80(1-3):129-44.
•   Polee MB, Tilanus HW, Eskens FA, Hoekstra R, Van der Burg ME, Siersema PD, Stoter G, Van der Gaast A
  Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus. Ann Oncol. 2003 Aug;14(8):1253-7.
•   Scheithauer W
  Esophageal cancer: chemotherapy as palliative therapy. Ann Oncol. 2004;15 Suppl 4:iv97-100. Review.
•   Westerterp M, Koppert LB, Buskens CJ, Tilanus HW, ten Kate FJ, Bergman JJ, Siersema PD, van Dekken H, van Lanschot JJ
  Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch. 2005 May;446(5):497-504. Epub 2005 Apr 19.

Combination Treatment of S-1 With Paclitaxel Versus Paclitaxel+Cisplatin and 5-Fu+Cisplatin as First-line Treatment in Advanced Esophageal Cancer

Details for clinical trial NCT01704690